Virtual Screening for Identification of Pyridines and Pyrimidines as Potent CDK9 Inhibitors

Cyclin-dependent kinase 9 (CDK9) has emerged as a promising therapeutic target for various cancers and viral infections due to its crucial role in cell cycle regulation and transcriptional control. In this study, we present a comprehensive virtual screening approach aimed at identifying novel pyridine and pyrimidine derivatives as potent CDK9 inhibitors. Utilizing computational tools and molecular docking simulations, we screened a large chemical library to prioritize compounds with favorable binding affinities and pharmacokinetic properties. Subsequent in silico ADMET (absorption, distribution, metabolism, excretion, and toxicity) analysis was employed to assess the drug-likeness and safety profile of the identified candidates. The top-ranking compounds were further evaluated through molecular dynamics simulations to elucidate their dynamic behavior and stability within the CDK9 binding pocket. Our findings reveal several promising pyridine and pyrimidine derivatives with potential CDK9 inhibitory activity, warranting further experimental validation and optimization for therapeutic development against cancer and other CDK9-associated diseases. This integrative computational approach demonstrates its efficacy in accelerating drug discovery efforts and offers valuable insights into structure-activity relationships for the design of novel CDK9 inhibitors.